Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Corcept Therapeutics Incorporated (CORT)

14.32 -0.38 (-0.21%)

09-24 16:00

Open:

14.7

Pre. Close:

14.35

High:

14.7

Low:

14.17

Volume:

635,286

Market Cap:

1662M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

14.728 - 14.812

14.812 - 14.903

Low:

13.939 - 14.03

14.03 - 14.129

Close:

14.147 - 14.306

14.306 - 14.48

Technical analysis  (as of: 2018-09-24 4:38:13 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 17.65     One year: 20.61

Support:

Support1: 13.66    Support2: 12.77

Resistance:

Resistance1: 15.11    Resistance2: 17.65

Pivot:

14.49

Moving Averages:

MA(5): 14.37     MA(20): 14.48

MA(100): 15.48     MA(250): 17.07

MACD:

MACD(12,26): 0.13     Signal(12,26,9): 0.16

%K %D:

%K(14,3): 40.81     %D(3): 42.11

RSI:

RSI(14): 50.72

52-Week:

High: 25.96  Low: 11.55  Change(%): -23.5

Average Vol(K):

3-Month: 129817  10-Days 105264

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CORT has closed above bottom band by 32.7%. Bollinger Bands are 63% narrower than normal. The narrow width of the bands suggests low volatility as compared to CORT's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-09-20T11:33:30-04:00
Corcept Therapeutics - Growth Investor's Biotech Pick

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

116.05

Shares Float (M)

106.62

% Held by Insiders

% Held by Institutions

63.80

Shares Short (K)

15871

Shares Short Prior Month (K)

Stock Financials

EPS

0.560

EPS Est. Current Year

0.420

EPS Est. Next Year

0.700

EPS Est. Next Quarter

0.150

Forward EPS

1.420

Book Value (p.s.)

7.000

PEG Ratio

-2.41

Profit Margin

67.88

Operating Margin

35.62

Return on Assets (ttm)

81.4

Return on Equity (ttm)

95.0

Qtrly Rev. Growth

75.2

Gross Profit (p.s.)

0.360

Sales Per Share

EBITDA (p.s.)

0.118

Qtrly Earnings Growth

43.90

Operating Cash Flow (M)

85.45

Levered Free Cash Flow (M)

59.29

Valuation

P/E

25.57

P/E Growth Ratio

P/BV

2.05

P/S

883955264.00

P/CF

19.45

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.